Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System Version 2016: Application of the Diagnostic Algorithm and Feedback on 1,773 Liver Lesions

Wei Zheng,Jianhua Zhou,Xuebin Zou,Fei Li,Jianwei Wang,Feng Han

DOI: https://doi.org/10.1016/j.ultrasmedbio.2017.08.1079

2017-01-01

Abstract:To evaluate the diagnosis performance of the American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) version 2016 (v2016). A total of 1610 HBV-positive patients with 1773 untreated CEUS-detected liver nodules were analyzed retrospectively and categorized as CEUS LI-RADS categories 1-5 and M (LR-1-5 and -M) according to CEUS LI-RADS v2016. All lesions were pathologically and/or clinically confirmed with a minimum of 1-year follow-up. The rates of malignancy or HCC were calculated. Of 1773 lesions, 8.4% had a LR-1 and -2 assessment; 10.2%, a LR-3 assessment; 7.4%, a LR-4 assessment; 56.5%, a LR-5 assessment; and 17.5%, a LR-M assessment based on initial CEUS images. The malignancy rates of LR-3, -4, -5, and -M lesions were 11.0%, 87.0%, 98.9%, and 99.4%, respectively; and the HCC rates were 9.4%, 80.2%, 97.5%, and 71.0%, respectively. Of 310 LR-M lesions, 213 (68.7%, with 192 HCCs (90.1%)) presenting as distinct solid nodules with arterial phase hyperenhancement (APHE) (in whole or in part, not rim or peripheral discontinuous globular enhancement), only with early (within 60 seconds) or marked washout, were recategorized as LR-5. The HCC rates of LR-5 and -M were adjusted to 96.2% and 28.9%. As LR-M lesions have a high HCC rate, a recommendation of recategorizing nodules with APHE and early or marked washout as LR-5 may be appropriate.